AbbVie Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
AbbVie Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2013 to Q3 2024.
  • AbbVie Inc. Entity Common Stock, Shares Outstanding for the quarter ending October 28, 2024 was 1.77B shares, a 0.09% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.77B +1.6M +0.09% Oct 28, 2024 10-Q 2024-11-04
Q2 2024 1.77B +1.3M +0.07% Jul 29, 2024 10-Q 2024-08-07
Q1 2024 1.77B +1.58M +0.09% Apr 25, 2024 10-Q 2024-05-03
Q4 2023 1.77B -2.93M -0.17% Jan 31, 2024 10-K 2024-02-20
Q3 2023 1.77B -2.94M -0.17% Oct 27, 2023 10-Q 2023-11-06
Q2 2023 1.77B -3.05M -0.17% Jul 31, 2023 10-Q 2023-08-07
Q1 2023 1.76B -2.82M -0.16% Apr 25, 2023 10-Q 2023-05-05
Q4 2022 1.77B +646K +0.04% Jan 31, 2023 10-K 2023-02-17
Q3 2022 1.77B +600K +0.03% Oct 26, 2022 10-Q 2022-11-04
Q2 2022 1.77B +921K +0.05% Jul 27, 2022 10-Q 2022-08-04
Q1 2022 1.77B +888K +0.05% Apr 27, 2022 10-Q 2022-05-06
Q4 2021 1.77B +2.87M +0.16% Jan 31, 2022 10-K 2022-02-18
Q3 2021 1.77B +2.41M +0.14% Oct 25, 2021 10-Q 2021-11-02
Q2 2021 1.77B +2.34M +0.13% Jul 26, 2021 10-Q 2021-08-02
Q1 2021 1.77B +289M +19.6% Apr 28, 2021 10-Q 2021-05-07
Q4 2020 1.77B +287M +19.4% Jan 31, 2021 10-K 2021-02-19
Q3 2020 1.77B +287M +19.4% Oct 27, 2020 10-Q 2020-11-04
Q2 2020 1.76B +286M +19.4% Jul 28, 2020 10-Q 2020-08-04
Q1 2020 1.48B -1.59M -0.11% Apr 30, 2020 10-Q 2020-05-08
Q4 2019 1.48B +4.07M +0.28% Jan 31, 2020 10-K 2020-02-21
Q3 2019 1.48B -25.4M -1.69% Oct 29, 2019 10-Q 2019-11-06
Q2 2019 1.48B -35.8M -2.36% Jul 29, 2019 10-Q 2019-08-05
Q1 2019 1.48B -109M -6.84% Apr 26, 2019 10-Q 2019-05-03
Q4 2018 1.48B -113M -7.11% Feb 8, 2019 10-K 2019-02-27
Q3 2018 1.5B -92.2M -5.78% Oct 31, 2018 10-Q 2018-11-07
Q2 2018 1.51B -79.8M -5.01% Jul 31, 2018 10-Q 2018-08-07
Q1 2018 1.59B -4.66M -0.29% Apr 27, 2018 10-Q 2018-05-04
Q4 2017 1.59B -5.95M -0.37% Feb 2, 2018 10-K 2018-02-16
Q3 2017 1.6B -28.7M -1.76% Oct 24, 2017 10-Q 2017-11-07
Q2 2017 1.59B -34.4M -2.12% Jul 24, 2017 10-Q 2017-08-07
Q1 2017 1.59B -25.8M -1.6% Apr 24, 2017 10-Q 2017-05-05
Q4 2016 1.59B -17.3M -1.08% Jan 31, 2017 10-K 2017-02-17
Q3 2016 1.63B -9.65M -0.59% Oct 24, 2016 10-Q 2016-11-07
Q2 2016 1.63B -26.7M -1.62% Jun 30, 2016 10-Q 2016-08-05
Q1 2016 1.62B +24.3M +1.52% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 1.61B +17.4M +1.09% Jan 31, 2016 10-K 2016-02-19
Q3 2015 1.63B +41.5M +2.6% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 1.66B +63.6M +3.99% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 1.59B +3.01M +0.19% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 1.59B +5.37M +0.34% Jan 31, 2015 10-K 2015-02-20
Q3 2014 1.59B +2.4M +0.15% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 1.59B +6.27M +0.4% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 1.59B +6.34M +0.4% Mar 31, 2014 10-Q 2014-05-09
Q4 2013 1.59B Jan 31, 2014 10-K 2014-02-21
Q3 2013 1.59B Sep 30, 2013 10-Q 2013-11-12
Q2 2013 1.59B Jun 30, 2013 10-Q 2013-08-09
Q1 2013 1.58B Mar 31, 2013 10-Q 2013-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.